首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis of 1-(3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl)- 3-substituted-thiourea derivatives as antituberculosis agents.
【24h】

Synthesis of 1-(3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl)- 3-substituted-thiourea derivatives as antituberculosis agents.

机译:1-(3-(4-苯并三唑-1 / 2-基-3-氟-苯基)-2-氧代-恶唑烷-5-基甲基)-3-取代的硫脲衍生物的合成作为抗结核剂。

获取原文
获取原文并翻译 | 示例
           

摘要

In continuation of our research program for new antituberculosis drugs, we have designed, synthesized and evaluated antimycobacterial activity of new series of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]- 3-substituted-thiourea derivatives against different Mycobacterium species i.e. M. tuberculosis, M. avium and M. intracellulare in an agar dilution method. Compound 17 exhibited excellent antimycobacterial activity (in vitro) against drug sensitive and resistant clinical isolates of M. tuberculosis. Its MIC value is equivalent to linezolid and superior to isoniazid against all these strains.
机译:在继续我们的抗结核新药研究计划的过程中,我们已经设计,合成和评估了新的1- [3-(4-苯并三唑-1 / 2-基-3-氟-苯基)-2-氧代系列药物的抗分枝杆菌活性。 -琼脂稀释法针对不同分枝杆菌种类,即结核分枝杆菌,鸟分枝杆菌和胞内分枝杆菌,对-恶唑烷-5-基甲基] -3-取代的硫脲衍生物。化合物17对结核分枝杆菌的药物敏感性和耐药性临床分离株表现出优异的抗分枝杆菌活性(体外)。对于所有这些菌株,其MIC值等于利奈唑胺,并且优于异烟肼。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号